国际眼科纵览

• 综述 • 上一篇    下一篇

基于视杆细胞光生物调节的方法治疗糖尿病视网膜病变的研究和应用

陈芝清1 刘海鹏2 郑定昌2   

  1. 1浙江大学医学院附属第二医院眼科中心浙江省眼科学重点实验室,杭州 310009;2 安格利亚鲁斯金大学, 英国切尔姆斯福德CM1 1SQ
  • 收稿日期:2019-06-25 出版日期:2019-12-22 发布日期:2019-12-26
  • 通讯作者: 陈芝清,Email:chenzhiqing@zju.edu.cn

Research and application of photobiomodulation of rod cells for diabetic retinopathy

Chen Zhiqing1, Liu Haipeng2, Zheng Dingchang2   

  1. 1 Eye Center of the Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Hangzhou 310009, China; 2 Anglia Ruskin University, Chelmsford, United Kingdom
  • Received:2019-06-25 Online:2019-12-22 Published:2019-12-26
  • Contact: Chen Zhiqing, Email:chenzhiqing@zju.edu.cn

摘要:

糖尿病视网膜病变(diabetic retinopathy, DR)是工作年龄人群第一位的致盲性疾病,目前尚无特效疗法。视杆细胞暗适应产生的缺氧可加剧氧化应激及视网膜缺氧,促进DR病情发展。近几年出现了基于视杆细胞光生物调节的新型生物物理学方法,通过在黑暗处使用光生物调节,以抑制视杆细胞活性来达到减少DR对视网膜的损害。在离体细胞与在体动物研究中,该疗法治疗DR取得一定效果;相关临床试验也初步证明其有效,为DR患者的治疗提供了新的选择。(国际眼科纵览,2019, 43: 373-376)

Abstract:

Diabetic retinopathy(DR)is a leading cause of blindness among working\|age adults. Currently there is no effective treatment for DR. Studies have proved that dark adaptation of rod cells could worsen DR by enhancing the oxidation stress and hypoxia in inner retina. Recently, a new biophysical treatment of DR has been proposed based on the photobiomodulation of rod cells. With continuous photobiomodulation in dark environment, the activity of rod cells could be inhibited to decrease the harm to retina. This treatment has been shown to be effective in in\|vitro cell and in\|vivo animal experiments. Recent clinical trials have also preliminarily validated its effectiveness, leading to the conclusion that this new method could provide an alternative for DR treatment.(Int Rev Ophthalmol, 2019, 43: 373-376)